<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="134">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05159401</url>
  </required_header>
  <id_info>
    <org_study_id>09052021</org_study_id>
    <nct_id>NCT05159401</nct_id>
  </id_info>
  <brief_title>The Use of Vibrational Methods of Influencing the Lungs to Restore Their Functional State</brief_title>
  <official_title>The Use of Vibrational Methods of Influencing the Lungs to Restore Their Functional State After Major Reconstructive Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Petrovsky National Research Centre of Surgery</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Petrovsky National Research Centre of Surgery</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There will be formed of groups for application of vibration methods on the lungs: the method&#xD;
      of vibroacoustic lung massage using the &quot;BARK VibroLUNG&quot; device; the method of oscillating&#xD;
      PEP therapy using Acapella DH Green; the method of hardware stimulation of cough with a&#xD;
      mechanical insufflator-aspirator Comfort Cough Plus (Comfortable cough Plus). As a control&#xD;
      group, classical manual chest massage with percussion and verbal stimulation of cough against&#xD;
      the background of chest compressions with a total duration of 15 minutes will be used&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The patient signs an informed consent to participate in the study after 10-12 hours tracheal&#xD;
      extubation and transfer of the patient to spontaneous respiration. The application of one or&#xD;
      another method of influence is carried out by the method of random sampling (the envelope&#xD;
      method). Next, a session is conducted using one of the methods of vibrational respiratory&#xD;
      therapy. We are exploring the gas composition of arterial blood is examined, spirometry, and&#xD;
      the respiratory rate is measured after 20 minutes of the procedure. Further, respiratory&#xD;
      therapy sessions are repeated 3 times a day for three days&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 15, 2021</start_date>
  <completion_date type="Anticipated">November 2023</completion_date>
  <primary_completion_date type="Anticipated">November 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the minute inspiratory lung volume</measure>
    <time_frame>hospitalisation period, an average of 1 week</time_frame>
    <description>Comparison of minute inspiratory lung volume befor/after research using a spirometer</description>
  </primary_outcome>
  <primary_outcome>
    <measure>arterial blood oxygenation level</measure>
    <time_frame>hospitalisation period, an average of 1 day</time_frame>
    <description>Comparison arterial blood oxygenation level before/after researchin the study of arterial blood</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SpO2 more than 92%</measure>
    <time_frame>hospitalisation period, an average of 3 day</time_frame>
    <description>Comparison of SpO2 by pulse oximeter befor/after research (SpO2&gt;92%)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the number of complications</measure>
    <time_frame>hospitalisation period, an average of 1 week</time_frame>
    <description>Comparison of the number of complications befor/after research</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>assessment of the duration of hospital stay</measure>
    <time_frame>hospitalisation period, an average of 1 week</time_frame>
    <description>Comparison of assessment of the duration of hospital stay befor/after research</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>the first group: the method of vibroacoustic lung massage using the &quot;BARK VibroLUNG&quot; device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>dynamics blood saturation by pulse oximeter,minute inspiratory lung volume befor/after research</description>
  </arm_group>
  <arm_group>
    <arm_group_label>the second group:the method of oscillating REР therapy using Acapella DH Green</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>dynamics blood saturation by pulse oximeter,minute inspiratory lung volume befor/after research</description>
  </arm_group>
  <arm_group>
    <arm_group_label>the third group:the method of hardware stimulation of cough (Comfortable cough Plus)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>dynamics blood saturation by pulse oximeter,minute inspiratory lung volume befor/after research</description>
  </arm_group>
  <arm_group>
    <arm_group_label>the fourth group:classical manual chest massage with percussion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>dynamics blood saturation by pulse oximeter,minute inspiratory lung volume befor/after research</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>prevention of respiratory failure</intervention_name>
    <description>Positive dynamics during CT or X-ray examinations in the form of reduction of hypoventilation zones, straightening of lung tissue</description>
    <arm_group_label>the first group: the method of vibroacoustic lung massage using the &quot;BARK VibroLUNG&quot; device</arm_group_label>
    <arm_group_label>the fourth group:classical manual chest massage with percussion</arm_group_label>
    <arm_group_label>the second group:the method of oscillating REР therapy using Acapella DH Green</arm_group_label>
    <arm_group_label>the third group:the method of hardware stimulation of cough (Comfortable cough Plus)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age from 18 years to 80 years inclusive.&#xD;
&#xD;
          2. Performed cardiac surgery in IC conditions.&#xD;
&#xD;
          3. The patient's consent to participate in this study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Lack of productive contact with the patient&#xD;
&#xD;
          2. Any disorder in the central nervous system in the perioperative period (acute&#xD;
             cerebrovascular accident, coma, posthypoxic encephalopathy), being on a ventilator.&#xD;
&#xD;
          3. Unstable hemodynamics or hemodynamically significant rhythm disturbances&#xD;
&#xD;
          4. Shocks of various etiologies&#xD;
&#xD;
          5. Inability to provide respiratory protection, high risk of aspiration&#xD;
&#xD;
          6. Refusal of the patient to participate in this study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>November 17, 2021</study_first_submitted>
  <study_first_submitted_qc>December 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 16, 2021</study_first_posted>
  <last_update_submitted>December 2, 2021</last_update_submitted>
  <last_update_submitted_qc>December 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

